跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Flamorel - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Flamorel
Approved
STANDARD
Flamorel
Flamingo Pharmaceuticals Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f7d56ff1d743fc14
Company
Flamingo Pharmaceuticals Ltd.
Type
Standard
Approval Details
Approval Id
f7d56ff1d743fc14
Drug Approval Philippines Name
Flamorel
Product Name
Flamorel
Registration Number
DR-XY27822
Brand Name
Flamorel
Generic Name
Norfloxacin
Dosage Form
Tablet
Dosage Strength
400 mg
Manufacturer
Flamingo Pharmaceuticals Ltd.
Importer
Hexagon Pharmaceuticals
Distributor
Hexagon Pharmaceuticals
Issuance Date
24 May 2022
Expiry Date
09 September 2027
Pharmacologic Category
Urinary Antiseptic
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f7d56ff1d743fc14
Type
Standard
Back to Philippines FDA Approvals